In smooth muscle cells and fibroblasts, AR signalling outcomes are distinct when compared to cancer cells, only sharing between 10 and 20% overlap in genes regulated by AR/DH, and similar overlap for AR DNA-binding profiles (Berry et al. 2008, Tanner et al. 2011, Leach et al. 2015). This evidence concerns the gene AR and cancer.